Close

DoKaSch signs climate-controlled ULD deal with Turkish Cargo

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

Real-Time Force Mapping Improving Vial Capping Performance

The final stage of the parenteral fill finish process...

Process Drift Detection Preventing Pharmaceutical Packaging Defects

In the highly regulated world of pharmaceutical manufacturing, maintaining...

Container-Equipment Interface Data Improving Capping Validation

The validation of sterile fill finish operations is one...
- Advertisement -

Turkish Cargo has signed a Master Rental Agreement with climate-controlled ULD supplier DoKaSch Temperature Solutions.

DoKaSch TS Opticooler containerThe company’s Opticooler is regarded as one of the safest containers for transporting temperature-sensitive products such as vaccines and other pharmaceuticals by air.

“As one of the leading airlines of the world, we provide our cargo clients with the best quality services to transport high-value pharma products. So the Opticooler is one of the natural choices and the Master Rental Agreement confirms that we have all the necessary procedures in place,” said Fatih Cigal, Turkish Cargo Senior Vice President Marketing.

The Opticooler, an electric air-conditioned container, can keep pharmaceuticals exactly within their temperature range, regardless of a tropical summer or arctic winter. With a very high fail-safety level, the ULD operates just like normal warehouse and a constant temperature can be maintained if the it is occasionally connected to the power grid.

“Turkish Airlines serves more destinations than any other airline. This means that our Opticoolers are now available to many more clients that need reliable temperature-controlled airfreight,” added Andreas Seitz, managing director of DoKaSch Temperature Solutions.

World Pharma Today brings together the global pharmaceutical industry — from R&D leaders and regulatory affairs professionals to manufacturers and distribution executives — through trusted editorial, market intelligence, and digital engagement.

Our 2026 Media Pack offers integrated solutions to reach your audience:

  • Magazine & Digital Editions Showcase your brand within premium pharmaceutical industry coverage read by executives and decision - makers worldwide.
  • Industry Insights & Reports Align with data - driven analysis, trend reports, and regional roundups across the global pharmaceutical and life sciences value chain.
  • Brand Authority & Credibility Position your company as a thought leader through expert commentary, interviews, and special features.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Latest stories

Related stories

Real-Time Force Mapping Improving Vial Capping Performance

The final stage of the parenteral fill finish process...

Process Drift Detection Preventing Pharmaceutical Packaging Defects

In the highly regulated world of pharmaceutical manufacturing, maintaining...

Container-Equipment Interface Data Improving Capping Validation

The validation of sterile fill finish operations is one...

Residual Seal Force Monitoring Optimizing Container Closure Integrity

The maintenance of sterility in pharmaceutical products depends fundamentally...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »